Efficacy of combined use of Low Intensity Laser Therapy and Ultraviolet Radiation in the treatment of Relapsing-Remitting Multiple Sclerosis patients
Not Applicable
- Conditions
- Multiple sclerosisNeurological - Multiple sclerosis
- Registration Number
- ACTRN12612001186842
- Lead Sponsor
- Shimaa Abdelalim Essa
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
During remission state, regardless of the duration of MS established diagnosis, but having not more than (6) on EDSS scale.
They are Free from any systemic vascular or blood disease, vasculitis, diabetes, liver disease, kidney failure, heart failure, traumatic brain injury (TBI), cerebrovascular accident (CVA), spinal cord injury, human immunosuppressive virus (HIV), hyperthyrodism, cancer or in risk of chemical or atomic radiation exposure.
Exclusion Criteria
If any patient develop an allergic reaction to phototherapy or passed into an Multiple Sclerosis relapse would be excluded from the study.
Patients who will miss more than 3 successive sessions would be excluded from the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method